Cost-effectiveness of transcatheter aortic valve implantation (TAVI) for aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluation

Cost-effectiveness of transcatheter aortic valve implantation (TAVI) for aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluation

Background: Calcific aortic stenosis (AS) is a common valvular heart disease. Patients with severe symptomatic AS typically survive less than 3 years. In such patients, intervention with surgical aortic valve replacement (SAVR) may increase survival. However, in some patients SAVR is associated with...

Full description

Bibliographic Details
Main Authors: R Orlando, M Pennant, S Rooney, S Khogali, S Bayliss, A Hassan, D Moore, P Barton
Format: Article
Language:English
Published: NIHR Journals Library 2013-08-01
Series:Health Technology Assessment
Subjects:
aortic stenosis
transcatheter aortic valve implantation
surgical aortic valve replacement
cost-effectiveness
heart disease
Online Access:https://doi.org/10.3310/hta17330

Internet

https://doi.org/10.3310/hta17330

Similar Items